Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.

AIMS Polymorphisms of the NOSIII gene and of the CYBA gene have been associated with a number of pathological conditions such as arterial hypertension, coronary artery disease, and myocardial infarction. Because endothelium-dependent vasodilation is impaired in these disorders, we hypothesized that polymorphisms of NOSIII or CYBA might modulate endothelial function of venous capacitance vessels already before cardiovascular disease becomes overt. METHODS Endothelium-dependent and -independent venodilation was assessed by measuring local vascular responses to bradykinin and sodium nitroprusside in the dorsal hand vein after preconstriction with phenylephrine in 72 healthy male Caucasians after careful exclusion of cardiovascular risk factors. Genotyping was performed for polymorphisms of the NOSIII gene (T-786C, G894T, (CA)(n)) and the CYBA gene (C242T). RESULTS Genotype distribution for each polymorphism followed the Hardy-Weinberg equilibrium. In all studied single nucleotide polymorphisms no significant difference between the respective genotypes and the venodilator response to either sodium nitroprusside or bradykinin was observed, and the number of CA repeat copies was not related to the venodilator response to bradykinin. Mean venodilation induced by bradykinin 50 ng min(-1) (+/-SEM) for homozygote carriers of the single nucleotide polymorphisms was 48.9 +/- 8.5% venodilation (G894T; wild type: 49.8 +/- 6.9), 50.3 +/- 11.0% venodilation (T-786C; wild type: 42.6 +/- 5.2), and 30.4 +/- 9.1% venodilation (C242T; wild type: 49.2 +/- 6.0), respectively. CONCLUSIONS This study suggests that the studied polymorphisms of NOSIII and CYBA do not significantly modulate endothelium-dependent venodilation in individuals without vascular risk factors.

[1]  P. Campbell,et al.  Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiency. , 1978, The American journal of physiology.

[2]  D. Rodbard,et al.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.

[3]  W. H. Aellig.  A new technique for recording compliance of human hand veins. , 1981, British journal of clinical pharmacology.

[4]  P. Vallance,et al.  Biphasic response to acetylcholine in human veins in vivo: the role of the endothelium. , 1990, Clinical science.

[5]  S. Scherer,et al.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. , 1993, The Journal of biological chemistry.

[6]  T. Blaschke,et al.  Mechanism of Bradykinin‐Induced Venodilation in Humans , 1993, Journal of cardiovascular pharmacology.

[7]  W. Haefeli,et al.  Responsiveness to Bradykinin in Veins of Hypercholesterolemic Humans , 1993, Circulation.

[8]  W. Haefeli,et al.  Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans. , 1993, The American journal of physiology.

[9]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[10]  T. Blaschke,et al.  Characterization of an inhibitor of nitric oxide synthase in human-hand veins. , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  M. Lathrop,et al.  Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. , 1994, Biochemical and biophysical research communications.

[12]  D. Webb,et al.  The pharmacology of human blood vessels in vivo. , 1995, Journal of vascular research.

[13]  Vanhoutte Pm,et al.  Kinins and Endothelial Control of Vascular Smooth Muscle , 1995 .

[14]  W. Haefeli,et al.  Substance P in human hand veins in vivo: Tolerance, efficacy, potency, and mechanism of venodilator action , 1996, Clinical pharmacology and therapeutics.

[15]  G. Fields,et al.  Promotion of Fibroblast Adhesion by Triple-helical Peptide Models of Type I Collagen-derived Sequences (*) , 1996, The Journal of Biological Chemistry.

[16]  D. Wink,et al.  Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*) , 1996, The Journal of Biological Chemistry.

[17]  K. Kanazawa,et al.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.

[18]  K. Nakao,et al.  A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese , 1998, Human Genetics.

[19]  H Yasue,et al.  Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. , 1998, Journal of the American College of Cardiology.

[20]  A. Hingorani,et al.  A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. , 1999, Circulation.

[21]  Herrmann,et al.  Polymorphisms of the endothelial nitric oxide synthase gene — no consistent association with myocardial infarction in the ECTIM study , 1999, European journal of clinical investigation.

[22]  A. Gardemann,et al.  The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. , 1999, Atherosclerosis.

[23]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[24]  K. Nakao,et al.  T(-786)--> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. , 2000, The American journal of cardiology.

[25]  Y. Fukuuchi,et al.  C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. , 2000, Stroke.

[26]  T. Rabelink,et al.  Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. , 2000, Hypertension.

[27]  M. Laule,et al.  High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. , 2000, Pharmacogenetics.

[28]  E. Fleck,et al.  Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase , 2000, Journal of hypertension.

[29]  A. Gotto,et al.  A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. , 2000, Circulation research.

[30]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[31]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[32]  E. Boerwinkle,et al.  Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. , 2001, American journal of hypertension.

[33]  W. Kirch,et al.  Heterogeneity in hand veins responses to acetylcholine is not associated with polymorphisms in the G-protein beta3-subunit (C825T) and endothelial nitric oxide synthase (G894T) genes but with serum low density lipoprotein cholesterol. , 2001, Pharmacogenetics.

[34]  G. FitzGerald,et al.  Twenty-first century phox: not yet ready for widespread screening. , 2001, Circulation.

[35]  J. Morrow,et al.  In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism. , 2001, Pharmacogenetics.

[36]  T. Ogihara,et al.  Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study , 2001, Journal of hypertension.

[37]  C. Mamotte,et al.  Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population , 2001, Journal of cardiovascular risk.

[38]  T. Cole,et al.  Glu298Asp Endothelial Nitric Oxide Synthase Gene Polymorphism Interacts With Environmental and Dietary Factors to Influence Endothelial Function , 2000, Circulation research.

[39]  Shotai Kobayashi,et al.  T-786C Polymorphism in Endothelial NO Synthase Gene Affects Cerebral Circulation in Smokers: Possible Gene-Environmental Interaction , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[40]  W. Haefeli,et al.  Rapid Detection of Polymorphisms of the Nitric Oxide Cascade , 2002, Clinical chemistry and laboratory medicine.

[41]  W. Haefeli,et al.  Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. , 2003, High altitude medicine & biology.